Citation

Murray SB, Griffiths S, Mond JM, Kean J, Blashill AJ. Drug Alcohol Depend. 2016; 165: 198-202.

Affiliation

Department of Psychology, San Diego State University, San Diego, CA, United States; SDSU/UCSD Joint Doctoral Program in Clinical Psychology, San Diego, CA, United States.

Copyright

(Copyright © 2016, Elsevier Publishing)

DOI

10.1016/j.drugalcdep.2016.06.008

PMID

27364377

Abstract

OBJECTIVE: Anabolic androgenic steroid (AAS) use has been robustly associated with negative body image, and eating- and muscularity-oriented psychopathology. However, with AAS being increasingly utilized for both appearance and athletic performance-related purposes, we investigated whether comorbid body image psychopathology varies as a function of motivation for usage.

METHOD: Self-reported motivation for current and initial AAS use was recorded amongst 122 AAS using males, alongside measures of current disordered eating and muscle dysmorphia psychopathology.

RESULTS: Those reporting AAS for appearance purposes reported greater overall eating disorder psychopathology, F(2, 118)=7.45, p=0.001, ηp(2)=0.11, and muscle dysmorphia psychopathology, F(2, 118)=7.22, p<0.001, ηp(2)=0.11, than those using AAS primarily for performance purposes. Additionally, greater dietary restraint, F(2, 116)=3.61, p=0.030, ηp(2)=0.06, functional impairment, F(2, 118)=3.26, p=0.042, ηp(2)=0.05, and drive for size, F(2, 118)=10.76, p<0.001, ηp(2)=0.15, was demonstrated in those using ASS for appearance purposes.

DISCUSSION: Motivation for AAS use may be important in accounting for differential profiles of body image psychopathology amongst users. Men whose AAS use is driven primarily by appearance-related concerns may be a particularly dysfunctional subgroup.

Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Language: en